Centamin PLC Board Committee Changes (8698W)

TIDMCEY

RNS Number : 8698W

Centamin PLC

24 April 2019

 
 For immediate release     24 April 2019 
 
 

Centamin plc ("Centamin" or "the Company")

(LSE:CEY, TSX:CEE)

Board Committee Changes

In accordance with the UKLA Listing Rule 9.6.11R (3), Centamin is pleased to announce the following Board committee changes:

-- Dr Sally Eyre, Independent Non-Executive Director, will join the Remuneration Committee, with immediate effect.

-- Mark Bankes, Independent Non-Executive Director, will join the Nomination Committee and step down from the Remuneration Committee, with immediate effect.

The Remuneration Committee now comprises of G. Edward Haslam (Chair), Mark Arnesen and Dr Sally Eyre.

The Nomination Committee now comprises of G. Edward Haslam (Chair), Mark Arnesen, Alison Baker and Mark Bankes.

Full Board Committee details including composition can be found on our website: https://www.centamin.com/investors/corporate-governance.

This announcement contains regulated information.

Enquiries

For further information, please visit the website www.centamin.com or contact:

 
 
   Centamin plc                               Buchanan 
   Andrew Pardey, Chief Executive Officer     Bobby Morse 
   Alexandra Carse, Investor Relations        Chris Judd 
   [e-mail]                [e-mail] 
 

_____________________________________________________________________________________________________

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCDGGDSRUDBGCX

(END) Dow Jones Newswires

April 24, 2019 02:01 ET (06:01 GMT)